MicroPort (00853): Tianzhihao (688277.SH) intends to acquire equity interest in Shanghai MicroPort Orthopedics Medical

Microport (00853) announced that on July 15, 2026, its subsidiary Suzhou MicroPort Orthopedics (Group) Co., Ltd. (Suzhou MicroPort) has signed an intention letter with Beijing Tianzhi Hang Medical Technology Co., Ltd. (Tianzhi Hang) (688277.SH). The letter pertains to Tianzhi Hang potentially acquiring the controlling equity interest of Suzhou MicroPort and Shanghai MicroPort Orthopedic Medical Technology Co., Ltd. (the target company, along with its subsidiaries, the "target group") from other shareholders, with the consideration to be paid in the form of newly issued shares by Tianzhi Hang. As of the date of the intention letter, Suzhou MicroPort holds 82.29% of the equity of the target company, which is accounted for as a subsidiary of the company and is the core operating entity of the group's international (non-China) orthopedic business. The target group is primarily engaged in hip and knee joint orthopedic reconstruction operations in overseas markets such as the United States, Japan, and Europe. The target group has been deeply involved in the orthopedic field for many years, focusing on the research, development, production, and sales of high-quality hip and knee joint innovative products that have undergone sufficient clinical validation, with a mature and scalable overseas sales network. Its representative product, the InnoX Knee Joint Prosthesis, has accumulated over 20 years of clinical application history, with a 17-year cumulative prosthesis retention rate of 98.8%, and a patient satisfaction rate of 95% according to research published in The Knee journal. The announcement states that the target group has a leading performance in joint prosthesis product line, along with mature marketing channels developed over the years that cover the overseas orthopedic market, while Tianzhi Hang has a strong foundation and leading advantages in the field of orthopedic surgery Siasun Robot & Automation. The synergies in business, strategy, and long-term objectives are highly compatible between the two parties. The potential transaction is expected to achieve strong cooperation by integrating their respective resources and strengths, releasing synergies far exceeding individual operations, and assisting both parties in achieving long-term performance growth. Through the potential transaction, both parties are expected to continuously enhance the scale, profitability, and risk resistance of Tianzhi Hang and the target group's business through gradual release of business integration and synergy effects, thereby increasing the long-term investment value of the group in the target group's business.